← Funder search

Uncle Kory Foundation

El Segundo, CA · EIN 464485313 990-PF tax year 2025“Preselected organizations only” box checked

Historical funder research: IRS Form 990-PF filings from US private foundations, showing who funded what in past years. This is not a list of currently open grant calls, and we do not track open RFPs from private foundations. From public IRS Form 990-PF filings (latest on file for this funder: tax year 2025). Coverage: tax years 2019–2025. Freshness: the IRS releases these returns 1.5–2+ years after the tax year ends, so 2025 is still partial and a funder's newest grants may not appear yet. Last updated: November 14, 2026. Filings can contain errors, so confirm current priorities and deadlines with the funder before applying.

Grants paid (tax yr 2025)
$585,579
Assets (fair market value)
$1,008,983
Median grant to orgs
$50,000
all loaded years
Grants in our data
51
since tax year 2022
Giving by tax year
$800,000
2022
16 grants
$121,190
2023
8 grants
$435,000
2024
11 grants
$585,579
2025
16 grants

Year 2025 is still partial because many returns have not been filed or released yet. That is a freshness issue — coverage in our dataset is tax years 2019–2025.

Top recipient states
CA$1,029,269
TX$300,000
NC$187,084
NY$175,000
IL$84,000
MN$50,000
MD$50,000
AL$50,000
Cause areas funded
Education19
Health Care1

Only 39.2% of this funder's organizational grants could be linked to an IRS cause code.

How to apply (from the 990-PF, tax year 2025)

The foundation checked the box saying it contributes only to preselected organizations and doesn't accept unsolicited requests.

Form & materials
Not stated
Deadlines
Not stated
Restrictions
Not stated
Recent grants to organizations
RecipientLocationPurpose (as filed)AmountTax yr
University of Southern CaliforniaLos Angeles, CATHE ROLE OF GABA TRANSAMINASE IN MEDULLOBLASTOMA LOCAL RECURRENCE AND ITS POTENTIAL AS A THERAPEUTIC TARGET IN MEDULLOBLASTOMA METASTASIS 3RD YEAR FUNDING$50,0002025
University of California San FranciscoSan Francisco, CADEFINING NEURAL DEPENDENT VULNERABILITIES IN GBM RADIATION SENSITIZATION USING FUNCTIONAL GENOMICS$50,0002025
University of Alabama at BirminghamBirmingham, ALTARGETING RECURRENT GLIOBLASTOMA CELLS USING COLLAGEN-BINDING IL-12 AND IL-7$50,0002025
The University of Texas MD Anderson Cancer CenterHouston, TXAUTOPHAGY INHIBITION TO SENSITIZE MEDULLOBLASTOMA TO ENHANCE NK CELL IMMUNOTHERAPY$50,0002025
The University of Texas MD Anderson Cancer CenterHouston, TXPROJECT FP00009152 - REPURPOSING MIGRAINE TREATMENTS FOR DIPG - 5TH YEAR FUNDING$50,0002025
The Ucla FoundationLos Angeles, CAHAPTEN-MODIFIED NEOANTIGENS AS IMMUNE TARGETS FOR GLIOBLASTOMA TREATMENT$50,0002025
Regents University of California Los AngelesLos Angeles, CACHARACTERIZING PTPRZ1 MECHANISM IN CANCER AS A THERAPEUTIC TARGET, 3RD YEAR FUNDING$50,0002025
Duke UniversityDurham, NCSIRPIGLENASTAT FOR TREATING GLIOBLASTOMA$50,0002025
Cornell UniversityIthaca, NYTO FUND PROJECT "REGULATION OF MYELOID CELLS BY FATTY ACID METABOLISM IN IRRADIATED GLIOBLASTOMA." 2ND YEAR RENEWAL$50,0002025
City of HopeDuarte, CATARGETING NON-CODING RNA PSEUDOURIDINE MODIFICATION FOR GLIOBLASTOMA THERAPY$50,0002025
Duke UniversityDurham, NC"THE CARE-BEAR PROPOSAL." 2ND YEAR RENEWAL; PORTION TRANSFERRED TO UNIVERSITY OF COLORADO. REMAINING FUNDS REIMBURSED AND THEN ALLOCATED TO UNIVERSITY OF COLORADO REGENTS.$33,5842025
The Mark Foundation for Cancer ResearchNew York, NYFOUNDATION GIFT FOR THE GBM INITIATIVE$25,0002025
Regents of the University of ColoradoAurora, CO"THE CARE-BEAR PROPOSAL." 2ND YEAR RENEWAL$16,4162025
Central Brain Tumor Registry of the United StatesHinsdale, ILGENERAL SUPPORT$5,0002025
Brain Tumor Epidemiology ConsortiumHinsdale, ILCHARACTERIZING PTPRZ1 MECHANISM IN CANCER AS A THERAPEUTIC TARGET, 3RD YEAR FUNDING$5,0002025
The Ucla FoundationLos Angeles, CATO SUPPORT THE WORK OF DR. CLOUGHESY AND DR. LIAU AT THE BRAIN TUMOR CENTER OF UCLA.$5792025
Childrens Hospital Los AngelesLos Angeles, CACEREBROSPINAL FLUID LIQUID BIOPSY ON PEDIATRIC EMBRYONAL CENTRAL NERVOUS SYSTEM TUMORS.$50,0002024
Duke UniversityDurham, NCTHE CARE-BEAR PROPOSAL.$50,0002024
Regents University of CaliforniaSanta Cruz, CACHARACTERIZING PTPRZ1 MECHANISM IN CANCER AS A THERAPEUTIC TARGET, 2ND YEAR FUNDING$50,0002024
The University of Texas MD Anderson Cancer CenterHouston, TXTO SUPPORT PROJECT "IDENTIFICATION OF NON-CANONICAL ANTIGENS OF DEVELOPMENT OF NOVEL IMMUNOTHERAPIES IN GLIOBLASTOMA.$50,0002024
City of HopeDuarte, CAFUNDING PROJECT ADVANCING IL13RA2-CAR T CELL THERAPY AGAINST GLIOBLASTOMA BY ENHANCING IFNSIGNALING$50,0002024
Cornell University - Weill Cornell MedicineIthaca, NYTO FUND PROJECT "REGULATION OF MYELOID CELLS BY FATTY ACID METABOLISM IN IRRADIATED GLIOBLASTOMA."$50,0002024
University of Southern CaliforniaLos Angeles, CATHE ROLE OF GABA TRANSAMINASE IN MEDULLOBLASTOMA LOCAL RECURRENCE AND ITS POTENTIAL AS A THERAPEUTIC TARGET IN MEDULLOBLASTOMA METASTASIS 2ND YEAR FUNDING$50,0002024
The Ucla FoundationLos Angeles, CATO THE NEUROSURGERY BRAIN TUMOR PROGRAM RESEARCH FUND (60358C) FOR DR. LINDA LIAU.$37,5002024
The Ucla FoundationLos Angeles, CAFOR THE UCLA BRAIN CANCER RESEARCH GIFT FUND (61893C) LED BY DR. CLOUGHESY.$37,5002024

Grants to individuals are counted but not named.

Researching funders for a client?

The free funder search finds foundations that funded organizations like your client's, by cause and location. Free templates: multi-client grant calendar, grant tracker. GrantCorral is a workspace for grant consultants with several clients; founding members get 60 days free on Consultant, no card required, then 50% off the first year if they stay.